Promising new drug may stop, and even cure, Huntington's disease
After an early phase clinical trial, the drug called IONIS-HTTRx, inhibited nerve-cell killing proteins
Washington
THE discovery of a drug that may stop, and perhaps even cure the fatal disease known as Huntington's, is being hailed as "historic" by Louise Vetter, president and CEO of the Huntington's Disease Society of America, and "phenomenal" and "fantastically promising" by Huntington's researchers, including the woman who discovered the genetic mutation that causes the disease.
"I'm ecstatic," said Professor Nancy Wexler, who in 1993 identified the mutation. "Huntington's is horrible, one of the worst diseases known to mankind, and certain death... We know it's a bad gene, making a bad protein, that makes people sick, that kills your brain cells. Anything that could impact that, we knew that there could be a cure."
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs
Starbucks points to weaker consumer as profit falls
Restaurant Brands tops estimates as Burger King overhaul pays off
Walmart to shut all health centers in US over lack of profitability
Coca-Cola raises annual sales forecast on global demand, higher prices